Header Logo

NIPUN VERMA

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Radiation Oncology
Address7200 CAMBRIDGE
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Verma N, Kaur P, Jalan R. Reply to: "Non-acute decompensation: Ready for clinical practice?" J Hepatol. 2025 Aug 25. PMID: 40865645.
      Citations:    Fields:    
    2. Verma N, Garg P, Kaur P, Munjal S, Vinod AP, Valsan A, Andreola F, Kumar P, Saeidinejad M, Engelmann C, De A, Premkumar M, Taneja S, Mookerjee RP, Duseja A, Jalan R. Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosis. J Hepatol. 2025 Aug 12. PMID: 40812668.
      Citations:    Fields:    
    3. Verma N, Angeli P, Jalan R. Stratification, Therapeutic Targeting and Towards Personalised Care in Cirrhosis. J Hepatol. 2025 Aug 01. PMID: 40752847.
      Citations:    Fields:    
    4. Premkumar M, Gupta E, Sandhu A, Sharma P, Nain J, Taneja S, Verma N, De A, Duseja A, Grover GS, Dhiman RK. Impact of Resistance Associated Substitutions and Predictors of Treatment Failure Following Direct-acting Antiviral Therapy in a Viral Hepatitis C Elimination Cohort. J Clin Exp Hepatol. 2025 Nov-Dec; 15(6):102601. PMID: 40611935; PMCID: PMC12213087.
      Citations:    
    5. Taneja S, Mehtani R, Ganesh CP, Rose S, Balaraja S, Rathi S, De A, Lamba D, Verma N, Premkumar M, Hans R, Sharma RR, Duseja A. Plasma Exchange With Corticosteroids as a Rescue Therapy for Severe Prolonged Cholestasis in Acute Viral Hepatitis. J Clin Exp Hepatol. 2025 Nov-Dec; 15(6):102594. PMID: 40611934; PMCID: PMC12213083.
      Citations:    
    6. Alkhouri N, Cheuk-Fung Yip T, Castera L, Takawy M, Adams LA, Verma N, Arab JP, Jafri SM, Zhong B, Dubourg J, Chen VL, Singal AK, D?az LA, Dunn N, Nadeem R, Wai-Sun Wong V, Abdelmalek MF, Wang Z, Duseja A, Almahanna Y, Omeish HA, Ye J, Harrison SA, Cristiu J, Arrese M, Robert S, Lai-Hung Wong G, Bajunayd A, Shao C, Kubina M, Dunn W. ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease. Am J Gastroenterol. 2025 Mar 27. PMID: 40146016.
      Citations: 1     Fields:    
    7. Sharma P, Premkumar M, Guru RR, Sandhu A, Kajal K, De A, Rathi S, Verma N, Taneja S, Singh V, Duseja AK. Post COVID Condition and Long-Term COVID-19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study. JGH Open. 2025 Mar; 9(3):e70142. PMID: 40135045; PMCID: PMC11932954.
      Citations:    
    8. Verma N, Kaur P, Garg P, Ranjan V, Ralmilay S, Rathi S, De A, Premkumar M, Taneja S, Roy A, Goenka M, Duseja A, Jalan R. Clinical and pathophysiological characteristics of non-acute decompensation of cirrhosis. J Hepatol. 2025 Sep; 83(3):670-681. PMID: 40056937.
      Citations:    Fields:    Translation:Humans
    9. Divyaveer S, Kashyap M, Kekan K, Premkumar M, Prajapati K, De A, Bhattacharya A, Prashar SS, Kaur K, Yadav AK, Kaur J, Tiwari V, Patil AN, Duseja AK, Verma N, Patil MR, Ramachandran R, Bagur V, Kohli HS. Comparison of DTPA camera-based Gates method versus plasma-clearance methods for assessment of GFR in cirrhosis: A pilot study. Indian J Gastroenterol. 2025 Mar 07. PMID: 40053054.
      Citations:    Fields:    
    10. Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, Hern?ndez JLP, Wentworth B, Asrani SK, Alessandria C, Abdelkader NA, Wong YJ, Xie Q, Pyrsopoulos NT, Kim SE, Fouad Y, Torre A, Cerda E, Ferrer JD, Maiwall R, Simonetto DA, Papp M, Orman ES, Perricone G, Sol? C, Lange CM, Farias AQ, Pereira G, Gadano A, Caraceni P, Thevenot T, Verma N, Kim JH, Vorobioff JD, Cordova-Gallardo J, Ivashkin V, Roblero JP, Maan R, Toledo C, Gioia S, Fassio E, Marino M, Nabilou P, Vargas V, Merli M, Goncalves LL, Rabinowich L, Krag A, Balcar L, Montes P, Mattos AZ, Bruns T, Mohammed A, Laleman W, Carrera E, Cabrera MC, Girala M, Samant H, Raevens S, Madaleno J, Kim RW, Arab JP, Presa J, Ferreira CN, Galante A, Allegretti AS, Takkenberg B, Marciano S, Sarin SK, Durand F, Gin?s P, Angeli P, Sol? E, Piano S, International Club of Ascites GLOBAL AKI team. Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025 05; 10(5):418-430. PMID: 40058397.
      Citations: 1     Fields:    Translation:Humans
    11. Garg P, Verma N, Valsan A, Sarohi V, Basak T, Gupta T, Kaur P, Ralmilay S, Singh S, De A, Premkumar M, Taneja S, Duseja A, Singh V, Bajaj JS. Proteomics-guided Biomarker Discovery, Validation, and Pathway Perturbation in Infection-related Acute Decompensation of Cirrhosis. Clin Gastroenterol Hepatol. 2025 Feb 07. PMID: 39924007.
      Citations: 1     Fields:    
    12. Zhang F, Chow RD, He E, Dong C, Xin S, Mirza D, Feng Y, Tian X, Verma N, Majety M, Zhang Y, Wang G, Chen S. Author Correction: Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy. Nat Biotechnol. 2025 Feb 03. PMID: 39901026.
      Citations:    Fields:    
    13. Zhang F, Chow RD, He E, Dong C, Xin S, Mirza D, Feng Y, Tian X, Verma N, Majety M, Zhang Y, Wang G, Chen S. Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy. Nat Biotechnol. 2025 Jan 16. PMID: 39820813.
      Citations: 2     Fields:    
    14. Divyaveer S, Kashyap M, Kekan K, Yadav AK, Kaur J, Premkumar M, Gandotra A, Prajapati K, De A, Duseja AK, Verma N, Aggarwal R, Venkatasubramanian V, Tiwari V, Bagur V, Patil AN, Safiq N, Kohli HS. Comparison of Measured Glomerular Filtration Rate Versus Estimated Glomerular Filtration Rate in Indian Cirrhotic Patients: Report of a Pilot Study. J Clin Exp Hepatol. 2025 Mar-Apr; 15(2):102464. PMID: 39760116; PMCID: PMC11697551.
      Citations:    
    15. Roy A, Kumar Y, Verma N. Coagulopathy in acute liver failure. Best Pract Res Clin Gastroenterol. 2024 Dec; 73:101956. PMID: 39709211.
      Citations:    Fields:    Translation:Humans
    16. Garg P, Verma N, Duseja A. Editorial: Decoding ACLF-Sub-Phenotyping to Advance Precision Medicine in Acute-on-Chronic Liver Failure. Authors' Reply. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1627-1628. PMID: 39468943.
      Citations:    
    17. Giri P, Taneja S, Sahni N, Bhujade H, Padhi BK, Karki T, Garg P, Rathi S, De A, Verma N, Premkumar M, Duseja A. Outpatient Intensive Nutrition Therapy Improves Survival and Frailty in Males With Alcohol-related ACLF - Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2025 Jun; 23(7):1164-1173.e2. PMID: 39461460.
      Citations:    
    18. Rosen BP, Li QV, Cho HS, Liu D, Yang D, Graff S, Yan J, Luo R, Verma N, Damodaran JR, Kale HT, Kaplan SJ, Beer MA, Sidoli S, Huangfu D. Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness. Nat Commun. 2024 10 17; 15(1):8966. PMID: 39419994; PMCID: PMC11487130.
      Citations:    
    19. Kaur P, Garg P, Verma N. Letter: Association of Myokines With Disease Progression and Outcomes in Patients With Alcohol-Associated Liver Disease-Authors' Reply'. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1639-1640. PMID: 39394721.
      Citations:    
    20. Verma N, Roy A, Valsan A, Garg P, Ralmilay S, Girish V, Kaur P, Rathi S, De A, Premkumar M, Taneja S, Goenka MK, Duseja A. Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multicentric Study. Am J Gastroenterol. 2025 Jan 01; 120(1):182-193. PMID: 39364890.
      Citations: 2     Fields:    Translation:Humans
    21. Verma N, Vinod AP, Singal AK. The pharmacological management of alcohol-related cirrhosis: what's new? Expert Opin Pharmacother. 2024 Oct; 25(14):1923-1941. PMID: 39360770.
      Citations:    
    22. Verma N, Garg P, Valsan A, Roy A, Mishra S, Kaur P, Rathi S, De A, Premkumar M, Taneja S, Singh V, Dhiman RK, Duseja AK, Kamath P. Identification of four novel acute-on-chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methods. Aliment Pharmacol Ther. 2024 Dec; 60(11-12):1534-1548. PMID: 39310931.
      Citations:    
    23. Kaur P, Verma N. Letter: Association of myokines with disease progression and?outcomes in patients with alcohol-associated liver disease-Authors' reply. Aliment Pharmacol Ther. 2024 Nov; 60(10):1477-1478. PMID: 39300846.
      Citations:    
    24. Verma N, Piano S. Regional disparities of infections in cirrhosis: a call for action. Lancet Gastroenterol Hepatol. 2024 11; 9(11):967-969. PMID: 39243796.
      Citations: 2     Fields:    Translation:Humans
    25. Premkumar M, Dhiman RK, Duseja A, Mehtani R, Taneja S, Gupta E, Gupta P, Sandhu A, Sharma P, Rathi S, Verma N, Kulkarni AV, Bhujade H, Chaluvashetty SB, Kalra N, Grover GS, Nain J, Reddy KR. Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program. Gastroenterology. 2024 Dec; 167(7):1429-1445. PMID: 39181168.
      Citations: 6     Fields:    Translation:HumansCells
    26. Kaur P, Verma N, Wadhawan A, Garg P, Ralmilay S, Kalra N, Baloji A, Dutta P, Sharma G, Rathi S, De A, Premkumar M, Taneja S, Duseja A, Singh V. Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in Decompensated Cirrhosis. J Clin Exp Hepatol. 2025 Jan-Feb; 15(1):102402. PMID: 39296665; PMCID: PMC11405804.
      Citations:    
    27. Kaur P, Verma N, Garg P, Ralmilay S, Wadhawan A, Nadda R, Prajapati J, Sharma G, Rathi S, De A, Premkumar M, Taneja S, Singal AK, Duseja A. Myokines are associated with progression, course and mortality in alcohol-associated liver disease. Aliment Pharmacol Ther. 2024 Oct; 60(8):1005-1020. PMID: 39135311.
      Citations:    
    28. De A, Bhagat N, Mehta M, Singh P, Rathi S, Verma N, Taneja S, Premkumar M, Duseja A. Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease. J Clin Exp Hepatol. 2025 Jan-Feb; 15(1):102400. PMID: 39282592; PMCID: PMC11399567.
      Citations:    
    29. Kumar A, Arora A, Choudhury A, Arora V, Rela M, Jothimani DK, Mahtab MA, Devarbhavi H, Eapen CE, Goel A, Yaghi C, Ning Q, Chen T, Jia J, Zhongping D, Hamid SS, Butt AS, Jafri W, Shukla A, Tan SS, Kim DJ, Saraya A, Hu J, Sood A, Goyal O, Midha V, Pati GK, Singh A, Lee GH, Treeprasertsuk S, Thanapirom K, Mandot A, Maghade R, Lesmana RC, Ghazinyan H, Mohan Prasad VG, Dokmeci AK, Sollano JD, Abbas Z, Shrestha A, Lau GK, Payawal DA, Shiha GE, Duseja A, Taneja S, Verma N, Rao PN, Kulkarni AV, Karim F, Saraswat VA, Alam S, Chowdhury D, Kedarisetty CK, Saigal S, Sharma P, Yattoo GN, Koshy A, Patwa AK, Elbasiony M, Rathi PM, Maharshi S, Dayal VM, Jha AK, Kalista KF, Gani RA, Yuen MF, Singh V, Sargsyan VA, Huang CH, Mukewar SS, Xin S, Rajaram RB, Panackel C, Dadhich S, Sachdeva S, Kumar A, Behera S, Kamani L, Saithanyamurthi HV, Prasad B, Sarin SK, APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party. Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure. Am J Gastroenterol. 2025 Apr 01; 120(4):816-826. PMID: 39016385.
      Citations:    
    30. Verma N, Johung KL, Kortmansky J, Zaheer W, Lacy J, Cecchini M, Stein S, Cheng YC, Lam W, Liu SH, Reddy V, Hochster H, Higgins SA. A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer. J Gastrointest Oncol. 2024 Jun 30; 15(3):1050-1059. PMID: 38989411; PMCID: PMC11231844.
      Citations:    
    31. Priya G L, Dhibar DP, Saroch A, Sharma N, Sharma V, Verma N, Chaluvashetty SB, Prakash A, Kaur H. Efficacy of empirical Ciprofloxacin or Cefixime plus Metronidazole therapy for the treatment of liver abscess: a randomized control clinical trial. Sci Rep. 2024 05 20; 14(1):11430. PMID: 38769330; PMCID: PMC11106291.
      Citations:    
    32. Roy A, Verma N, Jajodia S, Goenka U, Tiwari A, Sonthalia N, Goenka M. Magnetic resonance elastography (MRE) outperforms acoustic force radiation impulse (ARFI) in predicting oesophageal varices in obese NAFLD cirrhosis. Abdom Radiol (NY). 2024 09; 49(9):3088-3095. PMID: 38652124.
      Citations:    
    33. Maiwall R, Singh SP, Angeli P, Moreau R, Krag A, Singh V, Singal AK, Tan SS, Puri P, Mahtab M, Lau G, Ning Q, Sharma MK, Rao PN, Kapoor D, Gupta S, Duseja A, Wadhawan M, Jothimani D, Saigal S, Taneja S, Shukla A, Puri P, Govil D, Pandey G, Madan K, Eapen CE, Benjamin J, Chowdhury A, Singh S, Salao V, Yang JM, Hamid S, Jasuja S, Kulkarni AV, Niriella MA, Tevethia HV, Arora V, Mathur RP, Roy A, Jindal A, Saraf N, Verma N, De A, Choudhary NS, Mehtani R, Chand P, Rudra O, Sarin SK. APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure. Hepatol Int. 2024 Jun; 18(3):833-869. PMID: 38578541.
      Citations:    
    34. Verma N, De A, Duseja A. Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction-associated steatotic liver disease-authors' reply. Aliment Pharmacol Ther. 2024 04; 59(7):896-897. PMID: 38462705.
      Citations:    
    35. Thanapirom K, Treeprasertsuk S, Choudhury A, Verma N, Dhiman RK, Al Mahtab M, Devarbhavi H, Shukla A, Hamid SS, Jafri W, Tan SS, Lee GH, Ghazinyan H, Sood A, Kim DJ, Eapen CE, Tao H, Yuemin N, Dokmeci AK, Sahu M, Arora A, Kumar A, Kumar R, Prasad VGM, Shresta A, Sollano J, Payawal DA, Lau G, Sarin SK. Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients. Sci Rep. 2024 03 09; 14(1):5796. PMID: 38461166; PMCID: PMC10924893.
      Citations:    
    36. Garg P, Verma N, Angrup A, Taneja N, Valsan A, Reddy VD, Agarwal J, Chaudhary R, Kaur P, Rathi S, De A, Premkumar M, Taneja S, Duseja A. Exploring the Prevalence, Predictors, and Impact of Bacterial Infections to Guide Empiric Antimicrobial Decisions in Cirrhosis (EPIC-AD). J Clin Exp Hepatol. 2024 Jul-Aug; 14(4):101352. PMID: 38449507; PMCID: PMC10914474.
      Citations:    
    37. Verma N, Duseja A, Mehta M, De A, Lin H, Wong VW, Wong GL, Rajaram RB, Chan WK, Mahadeva S, Zheng MH, Liu WY, Treeprasertsuk S, Prasoppokakorn T, Kakizaki S, Seki Y, Kasama K, Charatcharoenwitthaya P, Sathirawich P, Kulkarni A, Purnomo HD, Kamani L, Lee YY, Wong MS, Tan EXX, Young DY. Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study. Aliment Pharmacol Ther. 2024 03; 59(6):774-788. PMID: 38303507.
      Citations:    
    38. Gandotra A, Taneja S, Premkumar M, Verma N, De A, Rathi S, Duseja A. Bloody Lips - Gluing Bleeding Lower Lip Spider Angioma in Decompensated Cirrhosis. J Clin Exp Hepatol. 2024 Mar-Apr; 14(2):101308. PMID: 38261889; PMCID: PMC10797178.
      Citations:    
    39. Premkumar M, Kajal K, Reddy KR, Izzy M, Kulkarni AV, Duseja AK, Sihag KB, Divyaveer S, Gupta A, Taneja S, De A, Verma N, Rathi S, Bhujade H, Chaluvashetty SB, Roy A, Kumar V, Siddhartha V, Singh V, Bahl A. Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography. Hepatology. 2024 05 01; 79(5):1048-1064. PMID: 37976391.
      Citations:    
    40. Kajal K, Premkumar M, Izzy M, Kulkarni AV, Duseja AK, Divyaveer S, Loganathan S, Sihag B, Gupta A, Bahl A, Rathi S, Taneja S, De A, Verma N, Sharma N, Kaur H, Zohmangaihi D, Kumar V, Bhujade H, Chaluvashetty SB, Kalra N. Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute-on-chronic liver failure with severe sepsis. Aliment Pharmacol Ther. 2023 11; 58(9):903-919. PMID: 37688403.
      Citations:    
    41. Rathi S, Kalantri A, Shastri A, Shree R, Mahesh KV, Taneja S, Chaluvasetty SB, Bhujade H, Verma N, Premkumar M, De A, Kalra N, Singh V, Duseja A. Endoscopic Ultrasound-Guided Transgastric Shunt Obliteration for Recurrent Hepatic Encephalopathy. Am J Gastroenterol. 2023 10 01; 118(10):1895-1898. PMID: 37589493.
      Citations:    
    42. Sharma S, Anand A, Verma N, Sharma V, Bhatia A, Patil AN, Banerjee D. Pharmacokinetic Assessment of Isoniazid and Acetylisoniazid in Carbon Tetrachloride-Induced Liver Injury Model in Wistar Rats. J Pharm Bioallied Sci. 2023 Jul-Sep; 15(3):139-145. PMID: 37705856; PMCID: PMC10496850.
      Citations:    
    43. Kaur P, Verma N, Valsan A, Garg P, Rathi S, De A, Premkumar M, Taneja S, Duseja A, Singh V, Dhiman RK. Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India. Dig Dis Sci. 2023 10; 68(10):4022-4038. PMID: 37578566.
      Citations:    
    44. Verma N, Singal AK. Editorial: The US burden of HRS-AKI-Putting numbers to the problem: Authors' reply. Aliment Pharmacol Ther. 2023 07; 58(1):122-123. PMID: 37307544.
      Citations:    
    45. Mehtani R, Premkumar M, Garg S, Kajal K, Kulkarni AV, Duseja AK, Dhiman RK, De A, Verma N, Taneja S, Rathi S, Singh V, Chakma J, Soni SL, Kakkar A, Kapila AT, Ahuja CK, Divyaveer S, Praharaj D. Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial. J Clin Exp Hepatol. 2023 Nov-Dec; 13(6):977-988. PMID: 37975059; PMCID: PMC10643498.
      Citations:    
    46. De A, Charak S, Bhagat N, Rathi S, Verma N, Premkumar M, Taneja S, Sharma A, Goel K, Singh V, Duseja A. Efficacy and safety of pan-genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on?dolutegravir-based antiretroviral therapy. J Viral Hepat. 2023 09; 30(9):740-745. PMID: 37260083.
      Citations:    
    47. Singh S, Taneja S, Roy A, Rathi S, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis. Indian J Gastroenterol. 2023 06; 42(3):379-387. PMID: 37222972.
      Citations:    
    48. Verma N, Divakar Reddy PV, Vig S, Angrup A, Biswal M, Valsan A, Garg P, Kaur P, Rathi S, De A, Premkumar M, Taneja S, Ray P, Duseja A, Singh V. Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis. JHEP Rep. 2023 Aug; 5(8):100788. PMID: 37484213; PMCID: PMC10362792.
      Citations:    
    49. Verma N, Vojjala N, Mishra S, Valsan A, Kaur R, Kaur T, De A, Premkumar M, Taneja S, Duseja A, Singh M, Singh V. Machine learning can guide suitability of consultation and patient referral through telemedicine for hepatobiliary diseases. J Gastroenterol Hepatol. 2023 Jun; 38(6):999-1007. PMID: 37114643.
      Citations:    
    50. Verma N, Garg P, Bhardwaj A, Sarohi V, Singh S. Candida leucine aminopeptidase: A novel mycoprotein linked to invasive candidiasis and mortality in acutely decompensated cirrhosis. J Hepatol. 2023 08; 79(2):e68-e71. PMID: 37037271.
      Citations:    
    51. Kaur A, Verma N, Singh B, Kumar A, Kumari S, De A, Sharma RR, Singh V. Quantitative liver SPECT/CT is a novel tool to assess liver function, prognosis, and response to treatment in cirrhosis. Front Med (Lausanne). 2023; 10:1118531. PMID: 37035316; PMCID: PMC10073445.
      Citations:    
    52. Mishra S, Taneja S, De A, Verma N, Premkumar M, Naidu GSRSNK, Sharma A, Duseja A, Dhiman RK, Singh V. Efficacy, Tolerability, and Compliance of Direct Acting Antivirals in Patients with HIV and Hepatitis C Coinfection: A Real-Life Experience. AIDS Res Hum Retroviruses. 2023 09; 39(9):453-458. PMID: 36511384.
      Citations:    
    53. Taneja S, Mehtani R, De A, Mitra S, Rathi S, Verma N, Premkumar M, Minz R, Duseja A, Das A, Singh V, Dhiman RK, Chawla YK. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital. J Clin Exp Hepatol. 2023 Mar-Apr; 13(2):241-251. PMID: 36950480; PMCID: PMC10025584.
      Citations:    
    54. Meena BL, Taneja S, Tandon P, Sahni N, Soundararajan R, Gorsi U, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial. J Gastroenterol Hepatol. 2023 Feb; 38(2):210-218. PMID: 36268614.
      Citations:    
    55. Verma N, Choudhury A, Singh V, Duseja A, Al-Mahtab M, Devarbhavi H, Eapen CE, Goel A, Ning Q, Duan Z, Hamid S, Jafri W, Butt AS, Shukla A, Tan SS, Kim DJ, Hu J, Sood A, Goel O, Midha V, Ghaznian H, Sahu MK, Lee GH, Treeprasertsuk S, Shah S, Lesmana LA, Lesmana RC, Prasad VGM, Sarin SK, APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party. APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients. Liver Int. 2023 Feb; 43(2):442-451. PMID: 35797245.
      Citations:    
    56. Singh A, De A, Singh MP, Rathi S, Verma N, Premkumar M, Taneja S, Duseja A, Singh V. Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study. Dig Dis Sci. 2023 02; 68(2):676-684. PMID: 36156752; PMCID: PMC9510448.
      Citations:    
    57. Premkumar M, Mehtani R, Kulkarni AV, Duseja AK, De A, Taneja S, Singh V, Verma N, Ahluwalia J, Kajal K, Divyaveer S, Roy A, Gandotra A, Kalson N, Kekan K, Kaur H, Kaur H. Association of Heparin-Like Effect, Factor VII/XIII Deficiency and?Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding. Dig Dis Sci. 2023 02; 68(2):497-513. PMID: 35984611; PMCID: PMC9389477.
      Citations:    
    58. Verma N, Singh S, Roy A, Valsan A, Garg P, Pradhan P, Chakrabarti A, Singh M. Cirrhosis and fungal infections-a cocktail for catastrophe: A systematic review and meta-analysis with machine learning. Mycoses. 2022 Sep; 65(9):844-858. PMID: 35713607.
      Citations:    
    59. Singh V, Kumar P, Verma N, Vijayvergiya R, Singh A, Bhalla A. Propranolol vs. band ligation for primary prophylaxis of variceal hemorrhage in cirrhotic patients with ascites: a randomized controlled trial. Hepatol Int. 2022 Aug; 16(4):944-953. PMID: 35672572.
      Citations:    
    60. Bhagat N, Verma N, Singh V. HCC prediction post SVR: Many tools yet limited generalizability! J Hepatol. 2022 10; 77(4):1226-1228. PMID: 35526784.
      Citations:    
    61. Roy A, Verma N, Singh S, Pradhan P, Taneja S, Singh M. Immune-mediated liver injury following COVID-19 vaccination: A systematic review. Hepatol Commun. 2022 09; 6(9):2513-2522. PMID: 35507736; PMCID: PMC9348067.
      Citations:    
    62. Verma N, Asrani SK. Deep learning and non-invasive assessment of significant fibrosis: does adding more toppings improve the flavor of prediction? Hepatol Int. 2022 06; 16(3):492-494. PMID: 35359195.
      Citations:    
    63. Sharma A, Roy A, Premkumar M, Verma N, Duseja A, Taneja S, Grover S, Chopra M, Dhiman RK. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial. Hepatol Int. 2022 Apr; 16(2):433-446. PMID: 35349076.
      Citations:    
    64. Venkitaraman A, De A, Verma N, Kumari S, Leishangthem B, Sharma RR, Kalra N, Grover S, Singh V. Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT. Hepatol Int. 2022 Oct; 16(5):1127-1136. PMID: 35322373; PMCID: PMC8942063.
      Citations:    
    65. Kaur H, Dhiman RK, Kulkarni AV, Premkumar M, Singh V, Duseja AK, Grover S, Grover GS, Roy A, Verma N, De A, Taneja S, Mehtani R, Mishra S, Kaur H. Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study. J Viral Hepat. 2022 05; 29(5):395-406. PMID: 35266624.
      Citations:    
    66. Verma N, Roy A, Singh S, Pradhan P, Garg P, Singh M. Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis. Med Mycol. 2021 Dec 08; 60(1). PMID: 34734272.
      Citations:    
    67. Lan Y, Banks KM, Pan H, Verma N, Dixon GR, Zhou T, Ding B, Elemento O, Chen S, Huangfu D, Evans T. Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation. Cell Rep. 2021 12 07; 37(10):110095. PMID: 34879277; PMCID: PMC11229417.
      Citations:    
    68. Verma N, Singh S, Singh M, Chauhan A, Pradhan P, Jaiswal N, Chakrabarti A, Singh M. Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta-analysis. Mycoses. 2022 Mar; 65(3):266-284. PMID: 34724269.
      Citations:    
    69. Singh S, Taneja S, Tandon P, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study. J Clin Exp Hepatol. 2022 May-Jun; 12(3):800-807. PMID: 35677501; PMCID: PMC9168697.
      Citations:    
    70. Meena BL, Verma N, De A, Taneja S, Singh V. IgG4-Related Sclerosing Cholangitis with Cholecystitis Mimicking Cholangiocarcinoma: A Case Report. J Clin Exp Hepatol. 2022 May-Jun; 12(3):1012-1016. PMID: 35677498; PMCID: PMC9168706.
      Citations:    
    71. Verma N, Singh S, Syal A, Pradhan P, Singh M, Singh M. Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis. Med Mycol. 2021 Nov 03; 59(11):1092-1100. PMID: 34308965.
      Citations:    
    72. De A, Roy A, Verma N, Mishra S, Premkumar M, Taneja S, Singh V, Duseja A. Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta-analysis. Nephrology (Carlton). 2022 Jan; 27(1):82-89. PMID: 34453374.
      Citations:    
    73. Mishra S, Taneja S, De A, Muthu V, Verma N, Premkumar M, Duseja A, Singh V. Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum. J Clin Exp Hepatol. 2022 Mar-Apr; 12(2):278-286. PMID: 35535073; PMCID: PMC9077226.
      Citations:    
    74. Verma N, Mishra S, Singh S, Kaur R, Kaur T, De A, Premkumar M, Taneja S, Duseja A, Singh M, Singh V. Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID-19 Pandemic. Hepatol Commun. 2022 01; 6(1):65-76. PMID: 34230904; PMCID: PMC8251420.
      Citations:    
    75. Praharaj DL, Premkumar M, Roy A, Verma N, Taneja S, Duseja A, Dhiman RK. Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial. J Clin Exp Hepatol. 2022 Mar-Apr; 12(2):336-342. PMID: 35535057; PMCID: PMC9077172.
      Citations:    
    76. Singh S, Taneja S, Tandon P, Bansal A, Gorsi U, Roy A, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. J Clin Exp Hepatol. 2022 Mar-Apr; 12(2):398-408. PMID: 35535083; PMCID: PMC9077184.
      Citations:    
    77. Verma N, Dhiman RK, Choudhury A, Taneja S, Duseja A, Singh V, Al Mahtab M, Devarbhavi H, Shukla A, Ning Q, Hamid SS, Butt AS, Jafri W, Tan SS, Hu J, Zhongping D, Treeprasertsuk S, Lee GH, Ghazinyan H, Lesmana LA, Sood A, Midha V, Goyal O, Kim DJ, Eapen CE, Goel A, Tao H, Shaojie X, Yuemin N, Dokmeci AK, Sahu M, Singh A, Arora A, Kumar A, Kumar R, Prasad VGM, Shresta A, Sollano J, Payawal DA, Shah S, Rao PN, Kulkarni A, Lau GK, Sarin SK, APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure. Hepatol Int. 2021 Aug; 15(4):970-982. PMID: 34275111.
      Citations:    
    78. Verma N, Mehtani R, Duseja A. Universal definition and prognostication in acute-on-chronic liver failure - an unmet need! J Hepatol. 2022 01; 76(1):241-242. PMID: 34246704.
      Citations:    
    79. Verma N, Dhiman RK, Singh V, Duseja A, Taneja S, Choudhury A, Sharma MK, Eapen CE, Devarbhavi H, Al Mahtab M, Shukla A, Hamid SS, Jafri W, Butt AS, Ning Q, Chen T, Tan SS, Lesmana LA, Lesmana CRA, Sahu MK, Hu J, Lee GH, Sood A, Midha V, Goyal O, Ghazinian H, Kim DJ, Treeprasertsuk S, Mohan Prasad VG, Dokmeci AK, Sollano JD, Shah S, Payawal DA, Rao PN, Kulkarni A, Lau GK, Duan Z, Chen Y, Yokosuka O, Abbas Z, Karim F, Chowdhury D, Prasad AS, Sarin SK, APASL ACLF Working Party. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF. Hepatol Int. 2021 Jun; 15(3):753-765. PMID: 34173167.
      Citations:    
    80. De A, Keisham A, Mishra S, Mehta M, Verma N, Premkumar M, Taneja S, Das A, Singh V, Duseja A. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis?- Validation in an Indian Cohort. J Clin Exp Hepatol. 2022 Mar-Apr; 12(2):440-447. PMID: 35535068; PMCID: PMC9077185.
      Citations:    
    81. Valsan A, Verma N, Singh V. Letter to the Editor: Noninvasive Differentiation of Porto-sinusoidal Vascular Disease and Cirrhosis: The Devil Is in the Details! Hepatology. 2021 10; 74(4):2316-2317. PMID: 33977564.
      Citations:    
    82. Singh S, Verma N, Kanaujia R, Chakrabarti A, Rudramurthy SM. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses. 2021 Sep; 64(9):1015-1027. PMID: 34057252.
      Citations:    
    83. Dixon G, Pan H, Yang D, Rosen BP, Jashari T, Verma N, Pulecio J, Caspi I, Lee K, Stransky S, Glezer A, Liu C, Rivas M, Kumar R, Lan Y, Torregroza I, He C, Sidoli S, Evans T, Elemento O, Huangfu D. QSER1 protects DNA methylation valleys from de novo methylation. Science. 2021 04 09; 372(6538). PMID: 33833093; PMCID: PMC8185639.
      Citations:    
    84. Taneja S, Duseja A, Mehta M, De A, Verma N, Premkumar M, Dhiman RK, Singh V, Singh MP, Ratho RK, Ramachandran R, Kumar V, Kohli HS. Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis. Liver Int. 2021 04; 41(4):705-709. PMID: 33025685.
      Citations:    
    85. Soni D, Roy A, De A, Verma N, Singh V. MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy? Am J Gastroenterol. 2021 04; 116(4):836-837. PMID: 33982961.
      Citations:    
    86. Verma N, Mishra S, Singh S, De A, Premkumar M, Taneja S, Duseja A, Singh V. Prevalence, Predictors, and Outcomes of Esophageal Candidiasis in Cirrhosis: An Observational Study With Systematic Review and Meta-Analysis (CANDID-VIEW). J Clin Exp Hepatol. 2022 Jan-Feb; 12(1):118-128. PMID: 35068792; PMCID: PMC8766531.
      Citations:    
    87. Singh S, Singh M, Verma N, Sharma M, Pradhan P, Chauhan A, Jaiswal N, Chakrabarti A, Singh M. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis. Med Mycol. 2021 Feb 04; 59(2):139-148. PMID: 32448907.
      Citations:    
    88. Singh S, Verma N, Singh V. Letter to the Editor: MELD-Lactate-the New Kid on the Block. Hepatology. 2020 11; 72(5):1883. PMID: 32330335.
      Citations:    
    89. Mehtani R, Roy A, Verma N, Premkumar M, Singh V. Beta-blockers in refractory ascites - is it truly the end of the road? J Hepatol. 2020 11; 73(5):1290-1291. PMID: 32861511.
      Citations:    
    90. Verma N, Duseja A, Singh V. Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease. Gastroenterology. 2021 04; 160(5):1893-1894. PMID: 32553766; PMCID: PMC7837182.
      Citations:    
    91. Makkar K, Tomer S, Verma N, Rathi S, Arora SK, Taneja S, Duseja A, Chawla YK, Dhiman RK. Neutrophil dysfunction predicts 90-day survival in patients with acute on chronic liver failure: A longitudinal case-control study. JGH Open. 2020 Aug; 4(4):595-602. PMID: 32782944; PMCID: PMC7411642.
      Citations:    
    92. Krishan S, Dhiman RK, Kalra N, Sharma R, Baijal SS, Arora A, Gulati A, Eapan A, Verma A, Keshava S, Mukund A, Deva S, Chaudhary R, Ganesan K, Taneja S, Gorsi U, Gamanagatti S, Madhusudan KS, Puri P, Govil S, Wadhavan M, Saigal S, Kumar A, Thapar S, Duseja A, Saraf N, Khandelwal A, Mukhopadyay S, Gulati A, Shetty N, Verma N. Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System" [J Clin Expt Hepatol 9 (2019) 625-651]. J Clin Exp Hepatol. 2020 Mar-Apr; 10(2):188. PMID: 32189936; PMCID: PMC7068003.
      Citations:    
    93. Roy A, Verma N, Ahuja CK. Intracranial invasive mycosis mimicking hepatic encephalopathy in a patient with cirrhosis. BMJ Case Rep. 2019 Nov 26; 12(11). PMID: 31776153; PMCID: PMC6887396.
      Citations:    
    94. Singh S, Verma N, Taneja N. The human gut resistome: Current concepts & future prospects. Indian J Med Res. 2019 10; 150(4):345-358. PMID: 31823916; PMCID: PMC6902357.
      Citations:    
    95. Dhiman RK, Thumburu KK, Verma N, Chopra M, Rathi S, Dutta U, Singal AK, Taneja S, Duseja A, Singh M. Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis. Clin Gastroenterol Hepatol. 2020 04; 18(4):800-812.e25. PMID: 31476436.
      Citations:    
    96. Gupta T, Lochan D, Verma N, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla YK, Dhiman RK. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission. J Gastroenterol Hepatol. 2020 Mar; 35(3):461-466. PMID: 31334860.
      Citations:    
    97. Krishan S, Dhiman RK, Kalra N, Sharma R, Baijal SS, Arora A, Gulati A, Eapan A, Verma A, Keshava S, Mukund A, Deva S, Chaudhary R, Ganesan K, Taneja S, Gorsi U, Gamanagatti S, Madhusudan KS, Puri P, Govil S, Wadhavan M, Saigal S, Kumar A, Thapar S, Duseja A, Saraf N, Khandelwal A, Mukhopadyay S, Gulati A, Shetty N, Verma N. Joint Consensus Statement of the Indian National Association for Study of the Liver?and Indian Radiological and Imaging Association?for the Diagnosis and Imaging of Hepatocellular Carcinoma?Incorporating Liver Imaging Reporting and Data System. J Clin Exp Hepatol. 2019 Sep-Oct; 9(5):625-651. PMID: 31695253; PMCID: PMC6823668.
      Citations:    
    98. Tsai CJ, Verma N, Owosho AA, Hilden P, Leeman J, Yom S, Huryn JM, Lee NY, Estilo CL. Predicting radiation dosimetric distribution in different regions of the jaw in patients receiving radiotherapy for squamous cell carcinoma of the tonsil. Head Neck. 2019 10; 41(10):3604-3611. PMID: 31379059; PMCID: PMC7549841.
      Citations:    
    99. Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, Xu C, Wang Q, Soh CL, Yang D, Crespo M, Shukla A, Xiang Q, D?ndar F, Zumbo P, Witkin M, Koche R, Betel D, Chen S, Massagu? J, Garippa R, Evans T, Beer MA, Huangfu D. Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation. Nat Genet. 2019 06; 51(6):999-1010. PMID: 31110351; PMCID: PMC6545159.
      Citations:    
    100. Verma N, Singh S, Taneja S, Duseja A, Singh V, Dhiman RK, Chakrabarti A, Chawla YK. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int. 2019 03; 39(3):503-513. PMID: 30276951.
      Citations:    
    101. Teijeiro V, Yang D, Majumdar S, Gonz?lez F, Rickert RW, Xu C, Koche R, Verma N, Lai EC, Huangfu D. DICER1 Is Essential for Self-Renewal of Human Embryonic Stem Cells. Stem Cell Reports. 2018 09 11; 11(3):616-625. PMID: 30146489; PMCID: PMC6135725.
      Citations:    
    102. Verma N, Kaur A, Sharma R, Bhalla A, Sharma N, De A, Singh V. Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: A randomized trial. Hepatology. 2018 10; 68(4):1559-1573. PMID: 29278428.
      Citations:    
    103. Verma N, Vijayvergiya R, Grover S. Impact of balloon mitral valvotomy on quality of life and psychiatric morbidity in patients with severe mitral stenosis. Ind Psychiatry J. 2018 Jul-Dec; 27(2):285-292. PMID: 31359985; PMCID: PMC6592193.
      Citations:    
    104. Verma N, Singh A, Singh V. Reply. Hepatology. 2018 07; 68(1):388. PMID: 29500901.
      Citations:    
    105. Verma N, Pan H, Dor? LC, Shukla A, Li QV, Pelham-Webb B, Teijeiro V, Gonz?lez F, Krivtsov A, Chang CJ, Papapetrou EP, He C, Elemento O, Huangfu D. Author Correction: TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat Genet. 2018 05; 50(5):764. PMID: 29255265.
      Citations:    
    106. Verma N, Pan H, Dor? LC, Shukla A, Li QV, Pelham-Webb B, Teijeiro V, Gonz?lez F, Krivtsov A, Chang CJ, Papapetrou EP, He C, Elemento O, Huangfu D. Publisher Correction: TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat Genet. 2018 05; 50(5):764. PMID: 29255266.
      Citations:    
    107. Verma N, Singh A, Singh V. Haematopoietic stem cells in cirrhosis. Lancet Gastroenterol Hepatol. 2018 05; 3(5):298. PMID: 29644972.
      Citations:    
    108. Verma N, Kumar P, Mitra S, Taneja S, Dhooria S, Das A, Duseja A, Dhiman RK, Chawla Y. Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature. Hepatol Commun. 2018 02; 2(2):142-147. PMID: 29404521; PMCID: PMC5796329.
      Citations:    
    109. Verma N, Pan H, Dor? LC, Shukla A, Li QV, Pelham-Webb B, Teijeiro V, Gonz?lez F, Krivtsov A, Chang CJ, Papapetrou EP, He C, Elemento O, Huangfu D. TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat Genet. 2018 01; 50(1):83-95. PMID: 29203910; PMCID: PMC5742051.
      Citations:    
    110. Verma N, Singh S, Sawatkar G, Singh V. Sofosbuvir induced steven Johnson Syndrome in a patient with hepatitis C virus-related cirrhosis. Hepatol Commun. 2018 01; 2(1):16-20. PMID: 29404508; PMCID: PMC5776873.
      Citations:    
    111. Pulecio J, Verma N, Mej?a-Ram?rez E, Huangfu D, Raya A. CRISPR/Cas9-Based Engineering of the Epigenome. Cell Stem Cell. 2017 10 05; 21(4):431-447. PMID: 28985525; PMCID: PMC6205890.
      Citations:    
    112. Shi ZD, Lee K, Yang D, Amin S, Verma N, Li QV, Zhu Z, Soh CL, Kumar R, Evans T, Chen S, Huangfu D. Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development. Cell Stem Cell. 2017 05 04; 20(5):675-688.e6. PMID: 28196600; PMCID: PMC5419850.
      Citations:    
    VERMA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (289)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _